Farber HW - Search Results

1

An Unlikely Trio: Profound Anemia, Elevated Lactate, and Riociguat.

Farmer MJS, Farber HW. Farmer MJS, et al. Among authors: farber hw. Cureus. 2022 Jan 6;14(1):e20997. doi: 10.7759/cureus.20997. eCollection 2022 Jan. Cureus. 2022. PMID: 35154971 Free PMC article.

2

Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.

Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Hill NS, et al. Among authors: farber hw. Ann Am Thorac Soc. 2015 Feb;12(2):269-73. doi: 10.1513/AnnalsATS.201501-020AS. Ann Am Thorac Soc. 2015. PMID: 25590376

3

Gestational pulmonary arterial hypertension.

Moll M, Payne JG, Tukey MH, Farber HW. Moll M, et al. Among authors: farber hw. Pulm Circ. 2015 Dec;5(4):730-3. doi: 10.1086/683689. Pulm Circ. 2015. PMID: 26697182 Free PMC article.

4

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM. Humbert M, et al. Among authors: farber hw. Eur Respir J. 2019 Jun 5;53(6):1802004. doi: 10.1183/13993003.02004-2018. Print 2019 Jun. Eur Respir J. 2019. PMID: 30923187 Free PMC article. Clinical Trial.

5

Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.

Menon AA, Sahay S, Braverman LE, Farber HW. Menon AA, et al. Among authors: farber hw. Lung. 2019 Dec;197(6):761-768. doi: 10.1007/s00408-019-00283-8. Epub 2019 Nov 6. Lung. 2019. PMID: 31696306

6

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.

Wesley Milks M, Sahay S, Benza RL, Farber HW. Wesley Milks M, et al. Among authors: farber hw. J Heart Lung Transplant. 2021 Mar;40(3):172-182. doi: 10.1016/j.healun.2020.12.005. Epub 2020 Dec 19. J Heart Lung Transplant. 2021. PMID: 33414063 Free PMC article. Review.

7

Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia - A case series and systematic review.

Abston E, Hon S, Rodriguez-Lopez J, Moll M, Lanuti M, Farber HW, Wilson KC. Abston E, et al. Among authors: farber hw. Pulm Pharmacol Ther. 2021 Jun;68:102033. doi: 10.1016/j.pupt.2021.102033. Epub 2021 Apr 22. Pulm Pharmacol Ther. 2021. PMID: 33895318

8

Pulmonary Arterial Hypertension in Patients Infected with the Human Immunodeficiency Virus.

Hon SM, Alpizar-Rivas RM, Farber HW. Hon SM, et al. Among authors: farber hw. Cardiol Clin. 2022 Feb;40(1):45-54. doi: 10.1016/j.ccl.2021.08.004. Cardiol Clin. 2022. PMID: 34809916 Review.

9

A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis.

Kong K, Koontz D, Morse C, Roth E, Domsic RT, Simon MA, Stratton E, Buchholz C, Tobin-Finch K, Simms R, George MP, Hassoun PM, Farber H, Lafyatis R. Kong K, et al. J Scleroderma Relat Disord. 2021 Oct 1;6(3):242-246. doi: 10.1177/23971983211016196. Epub 2021 May 28. J Scleroderma Relat Disord. 2021. PMID: 35005243 Free PMC article.

10

Application of the REVEAL risk score calculator 2.0 in the CHEST study.

Benza RL, Farber HW, Frost AE, Ghofrani HA, Corris PA, Lambelet M, Nikkho S, Meier C, Hoeper MM. Benza RL, et al. Among authors: farber hw. Respir Med. 2022 Apr-May;195:106783. doi: 10.1016/j.rmed.2022.106783. Epub 2022 Mar 1. Respir Med. 2022. PMID: 35256218 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page